Latest News & Features
Refine Search
Americas
US biopharmaceutical company Sucampo has resolved patent litigation related to, and agreed a licensing deal for, its Amitiza (lubiprostone) capsules, used to treat constipation. 10 October 2014
Americas
Law firm Arnold & Porter LLP has appointed a new a partner to its life sciences team. 10 October 2014
Asia-Pacific
Criminal gangs in Australia are branching away from traditional forms of counterfeiting and are targeting pharmaceuticals, an Australian customs official has revealed. 9 October 2014
Genetics
A US appeals court has heard oral arguments in a case between Myriad Genetics and a generics company it wants to prevent from marketing its own test for BRCA gene mutations that can lead to breast cancer. 8 October 2014
Biotechnology
A patent belonging to Pluristem Therapeutics covering a treatment for ischemia has been upheld by the European Patent Office following opposition proceedings, the company has announced. 8 October 2014
Americas
US life sciences analysis company Sequenom has agreed a multi-million dollar deal to buy patents related to prenatal testing from UK-based technology transfer company Isis Innovation. 7 October 2014
Big Pharma
Pharmaceutical company CleveXel Pharma has agreed a deal with a technology transfer company to licence two patents related to the treatment of bone marrow cancer. 6 October 2014
Big Pharma
Drug business Teva invalidated two patents held by Leo Pharma today and will seek to launch a generic version of one of the company’s skin condition treatments. 6 October 2014
Americas
Law firm Blank Rome has expanded its litigation department with the appointment of life science specialist and partner Gary Ruckelshaus. 3 October 2014
Americas
US-based specialty drugs company Supernus Pharmaceuticals has sued generics maker Actavis, accusing it of infringing three patents related to an antiepileptic drug. 3 October 2014